Literature DB >> 16688492

Performance of a weight-related measure of Quality of Life in a psychiatric sample.

Ronette L Kolotkin1, Ross D Crosby, Patricia K Corey-Lisle, Hong Li, Jodi M Swanson.   

Abstract

The Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire has been validated previously in weight loss program participants and community volunteers. Because of the prevalence of obesity in individuals with schizophrenia and bipolar disorder, this study evaluates the psychometric performance of the IWQOL-Lite in these populations. A sample of 111 individuals with schizophrenia (mean age = 43.5; mean BMI = 32.6; 42.3% female; 59.5% Caucasian) and 100 with bipolar disorder (mean age = 42.8; mean BMI = 34.8; 66.0% female; 81.0% Caucasian) were recruited from four programs. Height and weight measurements were taken and participants completed the IWQOL-Lite, Medical Outcomes Study Short-Form-36 (SF-36), and Global Ratings of quality of life. Sixty-five participants completed the IWQOL-Lite 1-2 weeks later to determine stability of results. Sixty-four percent of schizophrenic participants and 68.0% of bipolar participants were obese. The IWQOL-Lite demonstrated excellent reliability in the current sample, with alpha coefficients ranging from 0.874 to 0.970 and test-retest coefficients ranging from 0.740 to 0.945. Correlations with collateral measures and BMI supported the construct validity of the IWQOL-Lite in this population. The IWQOL-Lite is a reliable and valid measure for assessing weight-related quality of life in individuals with schizophrenia and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688492     DOI: 10.1007/s11136-005-4627-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  40 in total

Review 1.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

Review 2.  Psychiatric medication induced obesity: an aetiologic review.

Authors:  S Virk; T L Schwartz; S Jindal; N Nihalani; N Jones
Journal:  Obes Rev       Date:  2004-08       Impact factor: 9.213

3.  Quality of life and overweight: the obesity related well-being (Orwell 97) questionnaire.

Authors:  E Mannucci; V Ricca; E Barciulli; M Di Bernardo; R Travaglini; P L Cabras; C M Rotella
Journal:  Addict Behav       Date:  1999 May-Jun       Impact factor: 3.913

4.  Prevalence of overweight and obesity in bipolar patients.

Authors:  J L Elmslie; J T Silverstone; J I Mann; S M Williams; S E Romans
Journal:  J Clin Psychiatry       Date:  2000-03       Impact factor: 4.384

5.  The impact of weight gain on quality of life among persons with schizophrenia.

Authors:  David B Allison; Joan A Mackell; Diana D McDonnell
Journal:  Psychiatr Serv       Date:  2003-04       Impact factor: 3.084

6.  Changes in body mass index for individuals with and without schizophrenia, 1987-1996.

Authors:  Peter Homel; Daniel Casey; David B Allison
Journal:  Schizophr Res       Date:  2002-06-01       Impact factor: 4.939

Review 7.  Gender differences in bipolar disorder.

Authors:  Lesley M Arnold
Journal:  Psychiatr Clin North Am       Date:  2003-09

8.  Quality of life of clients with schizophrenia.

Authors:  Sally Chan; Iu Wai Yu
Journal:  J Adv Nurs       Date:  2004-01       Impact factor: 3.187

Review 9.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Daniel J Müller; Pierandrea Muglia; Teresa Fortune; James L Kennedy
Journal:  Pharmacol Res       Date:  2004-04       Impact factor: 7.658

Review 10.  Quality of life and obesity.

Authors:  R L Kolotkin; K Meter; G R Williams
Journal:  Obes Rev       Date:  2001-11       Impact factor: 9.213

View more
  11 in total

1.  Content identification of the IWQOL-Lite with the International Classification of Functioning, Disability and Health.

Authors:  Annie Tessier; Nancy E Mayo; Alarcos Cieza
Journal:  Qual Life Res       Date:  2011-05       Impact factor: 4.147

2.  Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia.

Authors:  Omer Saatcioglu; Murat Kalkan; Nurhan Fistikci; Sakire Erek; Kasim Candas Kilic
Journal:  Psychiatr Q       Date:  2016-06

3.  Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial.

Authors:  Christoph U Correll; Linmarie Sikich; Gloria Reeves; Jacqueline Johnson; Courtney Keeton; Marina Spanos; Sandeep Kapoor; Kristin Bussell; Leslie Miller; Tara Chandrasekhar; Eva M Sheridan; Sara Pirmohamed; Shauna P Reinblatt; Cheryl Alderman; Abigail Scheer; Irmgard Borner; Terrence C Bethea; Sarah Edwards; Robert M Hamer; Mark A Riddle
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 4.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

Review 5.  Assessment tools in obesity - psychological measures, diet, activity, and body composition.

Authors:  Laura Beechy; Jennie Galpern; Andrew Petrone; Sai Krupa Das
Journal:  Physiol Behav       Date:  2012-04-24

6.  Psychometric evaluation of the IWQOL-Lite (Spanish version) when applied to a sample of obese patients awaiting bariatric surgery.

Authors:  Ana Andrés; Carmina Saldaña; Jordi Mesa; Albert Lecube
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 7.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Metabolic syndrome in bipolar disorders.

Authors:  Sandeep Grover; Nidhi Malhotra; Subho Chakrabarti; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2012-04

9.  Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial.

Authors:  Sarah S Casagrande; Gerald J Jerome; Arlene T Dalcin; Faith B Dickerson; Cheryl A Anderson; Lawrence J Appel; Jeanne Charleston; Rosa M Crum; Deborah R Young; Eliseo Guallar; Kevin D Frick; Richard W Goldberg; Meghan Oefinger; Joseph Finkelstein; Joseph V Gennusa; Oladapo Fred-Omojole; Leslie M Campbell; Nae-Yuh Wang; Gail L Daumit
Journal:  BMC Psychiatry       Date:  2010-12-13       Impact factor: 3.630

10.  Lifestyle related factors & impact of metabolic syndrome on quality of life, level of functioning & self-esteem in patients with bipolar disorder & schizophrenia.

Authors:  Nidhi Malhotra; Parmanand Kulhara; Subho Chakrabarti; Sandeep Grover
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.